Haleon (HLN) Cost of Revenue (2021 - 2023)
Haleon (HLN) posted Cost of Revenue of $4.1 billion for Q4 2023, up 211.26% on a QoQ basis from $1.3 billion in Q2 2023, and up 13.45% year-over-year from $3.6 billion in Q4 2022.
Haleon (HLN) Cost of Revenue (2021 - 2023) Analysis & Trends
Haleon's Cost of Revenue history runs 3 years deep, the most recent figure standing at $4.1 billion for Q4 2023.
- Quarterly Cost of Revenue rose 13.45% year-over-year to $4.1 billion in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $10.3 billion (changed N/A YoY) and the FY2025 annual result came in at $5.2 billion, down 7.59% from the prior year.
- Cost of Revenue was $4.1 billion for Q4 2023 at Haleon, up from $1.3 billion in the prior quarter.
- Across five years, Cost of Revenue topped out at $4.1 billion in Q4 2023 and bottomed at $1.3 billion in Q2 2023.
- A 3-year average of $2.7 billion and a median of $3.0 billion in 2022 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue declined 1.49% — and 2023, when it grew 13.45%.
- Haleon's Cost of Revenue stood at $3.6 billion in 2021, then slipped by 1.49% to $3.6 billion in 2022, then increased by 13.45% to $4.1 billion in 2023.
- Business Quant data shows HLN's Cost of Revenue at $4.1 billion in Q4 2023, $1.3 billion in Q2 2023, and $1.4 billion in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 46.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4.06 Bn |
| Dec 31, 2023 | 4.06 Bn |
| Jun 30, 2023 | 1.30 Bn |
| Jun 30, 2023 | 1.30 Bn |
| May 3, 2023 | 1.40 Bn |
| May 3, 2023 | 1.40 Bn |
| Dec 31, 2022 | 3.58 Bn |
| Dec 31, 2022 | 3.58 Bn |
| Sep 20, 2022 | 2.43 Bn |
| Sep 20, 2022 | 2.43 Bn |
| Dec 31, 2021 | 3.63 Bn |
| Dec 31, 2021 | 3.63 Bn |